Literature DB >> 32675145

Update on the diagnosis and management of Parkinson's disease.

Christopher Kobylecki1.   

Abstract

Parkinson's disease (PD) is diagnosed where bradykinesia occurs together with rigidity or tremor, in the presence of supporting features. The diagnosis is clinical, and attention should be paid to exclusion criteria indicating an alternative diagnosis and to 'red flag' features. There is no cure or disease-modifying treatment for PD, and the rate of progression is variable. The most effective symptomatic treatment remains levodopa, which has superior benefits for quality of life in early PD compared to other therapies. Motor fluctuations and dyskinesia later in the disease course can be improved with adjunctive treatments. Around 10% of patients per year with refractory motor fluctuations may be eligible for advanced therapies, including deep-brain stimulation surgery. There is emerging evidence for the management of non-motor symptoms in PD, and the importance of multidisciplinary care. In this article, the evidence base for optimal diagnosis and management of PD is discussed. © Royal College of Physicians 2020. All rights reserved.

Entities:  

Keywords:  Parkinson's disease; diagnosis; levodopa; non-motor symptoms; treatment

Mesh:

Substances:

Year:  2020        PMID: 32675145      PMCID: PMC7385761          DOI: 10.7861/clinmed.2020-0220

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  27 in total

1.  Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.

Authors:  Daniel Weintraub; Juergen Koester; Marc N Potenza; Andrew D Siderowf; Mark Stacy; Valerie Voon; Jacqueline Whetteckey; Glen R Wunderlich; Anthony E Lang
Journal:  Arch Neurol       Date:  2010-05

Review 2.  MDS clinical diagnostic criteria for Parkinson's disease.

Authors:  Ronald B Postuma; Daniela Berg; Matthew Stern; Werner Poewe; C Warren Olanow; Wolfgang Oertel; José Obeso; Kenneth Marek; Irene Litvan; Anthony E Lang; Glenda Halliday; Christopher G Goetz; Thomas Gasser; Bruno Dubois; Piu Chan; Bastiaan R Bloem; Charles H Adler; Günther Deuschl
Journal:  Mov Disord       Date:  2015-10       Impact factor: 10.338

3.  Randomized Delayed-Start Trial of Levodopa in Parkinson's Disease.

Authors:  Constant V M Verschuur; Sven R Suwijn; Judith A Boel; Bart Post; Bas R Bloem; Johannes J van Hilten; Teus van Laar; Gerrit Tissingh; Alexander G Munts; Guenther Deuschl; Anthony E Lang; Marcel G W Dijkgraaf; Rob J de Haan; Rob M A de Bie
Journal:  N Engl J Med       Date:  2019-01-24       Impact factor: 91.245

Review 4.  International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease.

Authors:  Susan H Fox; Regina Katzenschlager; Shen-Yang Lim; Brandon Barton; Rob M A de Bie; Klaus Seppi; Miguel Coelho; Cristina Sampaio
Journal:  Mov Disord       Date:  2018-03-23       Impact factor: 10.338

5.  Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial.

Authors:  Joaquim J Ferreira; Andrew Lees; José-Francisco Rocha; Werner Poewe; Olivier Rascol; Patrício Soares-da-Silva
Journal:  Lancet Neurol       Date:  2015-12-23       Impact factor: 44.182

6.  A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson's disease left untreated at diagnosis.

Authors:  D Grosset; L Taurah; D J Burn; D MacMahon; A Forbes; K Turner; A Bowron; R Walker; L Findley; O Foster; K Patel; C Clough; B Castleton; S Smith; G Carey; T Murphy; J Hill; U Brechany; P McGee; S Reading; G Brand; L Kelly; K Breen; S Ford; M Baker; A Williams; J Hearne; N Qizilbash; K Ray Chaudhuri
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-10       Impact factor: 10.154

Review 7.  When the going gets tough: how to select patients with Parkinson's disease for advanced therapies.

Authors:  Paul F Worth
Journal:  Pract Neurol       Date:  2013-03-13

8.  A clinicopathologic study of 100 cases of Parkinson's disease.

Authors:  A J Hughes; S E Daniel; S Blankson; A J Lees
Journal:  Arch Neurol       Date:  1993-02

9.  Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial.

Authors:  Nicolien M van der Kolk; Nienke M de Vries; Roy P C Kessels; Hilde Joosten; Aeilko H Zwinderman; Bart Post; Bastiaan R Bloem
Journal:  Lancet Neurol       Date:  2019-09-11       Impact factor: 44.182

10.  Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy.

Authors:  Luke A Massey; Caroline Micallef; Dominic C Paviour; Sean S O'Sullivan; Helen Ling; David R Williams; Constantinos Kallis; Janice L Holton; Tamas Revesz; David J Burn; Tarek Yousry; Andrew J Lees; Nick C Fox; Hans R Jäger
Journal:  Mov Disord       Date:  2012-04-04       Impact factor: 10.338

View more
  2 in total

1.  Artificial Intelligent Olfactory System for the Diagnosis of Parkinson's Disease.

Authors:  Wei Fu; Linxin Xu; Qiwen Yu; Jiajia Fang; Guohua Zhao; Yi Li; Chenying Pan; Hao Dong; Di Wang; Haiyan Ren; Yi Guo; Qingjun Liu; Jun Liu; Xing Chen
Journal:  ACS Omega       Date:  2022-01-26

2.  Comparative Effectiveness of Carbidopa-Levodopa Enteral Suspension and Deep Brain Stimulation on Parkinson's Disease-Related Pill Burden Reduction in Advanced Parkinson's Disease: A Retrospective Real-World Cohort Study.

Authors:  Michael J Soileau; Fernando Pagan; Alfonso Fasano; Ramon Rodriguez-Cruz; Lin Wang; Prasanna L Kandukuri; Connie H Yan; Ali Alobaidi; Yanjun Bao; Pavnit Kukreja; Mok Oh; Mustafa S Siddiqui
Journal:  Neurol Ther       Date:  2022-04-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.